Sign In

Parag Mehta

CEO at Aveta Biomics

Parag Mehta is the CEO of Aveta Biomics, a clinical-stage biopharmaceutical company based in the Boston area.12 He has been serving in this role since November 2013.1 Aveta Biomics focuses on developing novel Network Modulating Therapeutics to overcome drug resistance and off-target adverse effects, aiming to provide durable clinical responses.1

Under Parag's leadership, Aveta Biomics is:

  1. Conducting an ongoing clinical trial for Head and Neck cancer1
  2. Developing a new class of drugs to combat antibiotic resistance1
  3. Pioneering nature-inspired drugs using insights from evolutionary biology2

Parag G. Mehta holds a Ph.D. and serves not only as the CEO but also as a Board Director at Aveta Biomics.2 The company's platform is designed to create the next generation of first-in-class immuno-oncology drugs.2

In February 2022, Aveta Biomics, under Parag's leadership, secured an exclusive license from CSIR-Central Drug Research Institute (CDRI) for Caviunin-based drug compositions, expanding their portfolio into bone health drugs.3

Highlights

Dec 1 · avetabiomics.com
About – Avetabiomics
About – Avetabiomics
Feb 2 · prnewswire.com
Aveta Biomics and CSIR-CDRI Announce License to ... - PR Newswire

Related Questions

What are Parag Mehta's key achievements at Aveta Biomics?
How did Parag Mehta's experience at eInfochips prepare him for his role at Aveta Biomics?
What are the main challenges Parag Mehta has faced as CEO of Aveta Biomics?
How does Parag Mehta's leadership style impact Aveta Biomics' culture?
What innovative strategies has Parag Mehta implemented at Aveta Biomics?
Parag Mehta
Parag Mehta, photo 1
Parag Mehta, photo 2
Add to my network

Location

Bedford, Massachusetts, United States